Comorbidities associated with COVID‑19 mortality: A retrospective study in an intermediate care facility in Cape Town, South Africa
Article Sidebar
Main Article Content
Abstract
Background. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic continues to place a significant burden on healthcare systems across the globe. Previous studies have shown that patients with comorbidities who contract SARS-CoV-2 develop more severe COVID‑19 disease and are at a higher risk of mortality. However, literature in the intermediate care setting is limited.
Objectives. To evaluate the association between comorbidity and mortality in the intermediate care setting.
Methods. A retrospective observational study was performed at Brackengate Intermediate Care Facility (BICF), a 330-bed field hospital,
during the second wave of COVID‑19 in Cape Town, South Africa. Data of all adult patients admitted from 1 November 2020 to 28 February 2021 who met the inclusion criteria were analysed. Data were obtained from electronic hospital patient administration systems. Comparisons were made using χ2 or Fisher’s exact testing with a 5% level of confidence used to determine significance. Logistic regression models were used to investigate the independent association between clinical variables of interest and overall mortality.
Results. A total of 2 508 patients were analysed, of whom 2 476 (98.7%) were laboratory confirmed cases of COVID‑19. The median
number of admissions per day was 14. The mean age was 58 years, and 1 449 (57.8%) were female. The most prevalent comorbidities
were hypertension (62.6%), diabetes (46.9%) and obesity (28.0%), while 8.0% of patients were HIV-positive. The overall mortality was 13.3% (333/2 508). Patients with at least one comorbidity were 1.4 times more likely to die (odds ratio (OR) 2.4; 95% confidence interval (CI) 1.6 - 3.5), and this risk increased significantly with cumulative comorbidities. Patients who required >40% oxygen were at 5.5 (95% CI 4.3 - 7.1) times higher mortality risk. Variables independently associated with mortality were age >60 years, FiO2
>40%, previous cerebrovascular accident, concurrent tuberculosis infection and chronic kidney disease.
Conclusion. Patients with comorbidities are at an increased risk of death in COVID‑19 disease, and should be monitored closely. Oxygen requirement >40% is also associated with a higher likelihood of dying. Intermediate care facilities can provide valuable relief to acute care facilities by admitting high-risk patients for closer monitoring and management.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJPH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
How to Cite
References
Chen R, Liang W, Jiang M, et al. Risk factors of fatal outcome in hospitalised subjects with Coronavirus disease 2019 from a nationwide analysis in China. Chest 2020;158(1):97‐105. https://doi.org/10.1016%2Fj.chest.2020.04.010
Kim TS, Roslin M, Wang JJ, et al. BMI as a risk factor for clinical outcomes in patients hospitalised with COVID‐19 in New York. Obesity 2021;29(2):279‐284.
Albitar O, Ballouze R, Ooi JP, Sheikh Ghadzi SM. Risk factors for mortality among COVID‐19 patients. Diabetes Res Clin Pract 2020;166(108293):108293. https://doi.org/10.1016/j. diabres.2020.108293
Berenguer J, Ryan P, Rodríguez‐Baño J, et al. Characteristics and predictors of death among 4 035 consecutively hospitalised patients with COVID‐19 in Spain. Clin Microbiol Infect 2020;26(11):1525‐1536. https://doi.org/10.1016/j.cmi.2020.07.024
Abdool Karim SS, Churchyard GJ, Karim QA, Lawn SD. HIV infection and tuberculosis in South Africa: An urgent need to escalate the public health response. Lancet 2009;374(9693):921‐933. https://doi.org/10.1016/S0140‐6736(09)60916‐8
Jassat W, Cohen C, Tempia S, et al. Risk factors for COVID‐19‐related in‐hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: A cohort study. Lancet HIV 2021;8(9):e554‐567. https://doi.org/10.1016%2FS2352‐3018(21)00151‐X
Boulle A, Davies M‐A, Hussey H, et al. Risk factors for COVID‐19 death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis 2020;73(7):e2005‐e2015. https://doi.org/10.1093/cid/ciaa1198
Guan W‐J, Liang W‐H, Zhao Y, et al. Comorbidity and its impact on 1 590 patients with COVID‐19 in China: A nationwide analysis. Eur Respir J 2020;55(5):2000547. https://doi.org/ 10.1183%2F13993003.00547‐2020
Melis RJF, Olde Rikkert MGM, Parker SG, van Eijken MIJ. What is intermediate care? BMJ 2004;329(7462):360‐361. https://doi.org/10.1136/bmj.329.7462.360
Van der Westhuizen J‐N, Hussey N, Zietsman M, et al. Low mortality of people living with diabetes mellitus diagnosed with COVID‐19 and managed at a field hospital in Western Cape Province, South Africa. S Afr Med J 2021;111(10):961‐967. https://doi.org/10.7196/ samj.2021.v111i10.15779
Bulajic B, Ekambaram K, Saunders C, et al. A COVID‐19 field hospital in a conference centre – the Cape Town, South Africa experience. Afr J Prim Health Care Fam Med 2021;13(1):e1‐9. https://doi.org/10.4102/phcfm.v13i1.3140
Western Cape Government. Western Cape critical care triage tool. https://www. westerncape.gov.za/assets/departments/health/COVID19/western_cape_critical_care_ triage_tool_version_1.2_14th_may.pdf (accessed 23 January 2022).
Muhamad S‐A, Ugusman A, Kumar J, Skiba D, Hamid AA, Aminuddin A. COVID‐19 and hypertension: The what, the why, and the how. Front Physiol 2021;12:665064. https://doi. org/10.3389/fphys.2021.665064
South African Medical Research Council. The First South African National TB Prevalence Survey gives a clearer picture of the epidemic. Cape Town: SAMRC Advancing Life, 2021. https://www.samrc.ac.za/media‐release/first‐south‐african‐national‐tb‐prevalence‐ survey‐gives‐clearer‐picture‐epidemic (accessed 12 February 2021).
Wang Y, Feng R, Xu J, Hou H, Feng H, Yang H. An updated meta‐analysis on the association between tuberculosis and COVID‐19 severity and mortality. J Med Virol 2021;93(10):5682‐ 5686. https://doi.org/10.1002/jmv.27119
Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases, South Africa. Risk factors for Coronavirus disease 2019 (COVID‐19) death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis 2021;73(7):e2005‐2015. https://doi.org/10.1093/cid/ciaa1198